🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study evaluates the safety, immunogenicity and lot-to lot cons...
Status
Completed
Location
Optimal Research, LLC
Start Date
2016-07-11
Trial ID
NCT02839330
Studies have shown that a broader spectrum influenza vaccine may help in re...
Status
Completed
Location
Centro de Pesquisa Clínica Universidade Federal do Ceará - UFC (Site FOR01)
Start Date
2021-05-12
Trial ID
NCT03927131
Treatments Being Tested
The purpose of this study was to evaluate a single dose of FluBlok in terms...
Status
Completed
Location
Impact Clinical Trials
Start Date
2007-09-15
Trial ID
NCT00539981
The purpose of this research is to demonstrate immunologic equivalence of t...
Status
Completed
Location
Centro de Salud Galvan
Start Date
2007-11
Trial ID
NCT00617851
The present study is designed to evaluate in children (aged between 3 and 9...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-23
Trial ID
NCT00502593
Treatments Being Tested
The purpose of this study is to evaluate the immunologic equivalence of thr...
Status
Completed
Location
Anaheim Clincial Trials
Start Date
2014-09
Trial ID
NCT02256488
Treatments Being Tested
This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-22
Trial ID
NCT00289783
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Completed
Location
Indago Research & Health Center, Inc.
Start Date
2024-07-15
Trial ID
NCT06508320
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-16
Trial ID
NCT02096263
The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Status
Completed
Location
Headlands Research Scottsdale
Start Date
2025-03-07
Trial ID
NCT06864143
Treatments Being Tested